Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli

The complete genome sequence of Escherichia coli K-12.

Blattner, F., Plunkett, G., Bloch, C., Perna, N., Burland, V., Riley, M., Collado-Vides, J., Glasner, J. D., Rode, C., Mayhew, G., et al. (1997) · Science · doi:10.1126/science.277.5331.1453 · Cited by 7,996

Pathogenic Escherichia coli

Kaper, J. B., Nataro, J. P., & Mobley, H. L. T. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro818 · Cited by 5,583

Sex and virulence in Escherichia coli : an evolutionary perspective

Wirth, T., Falush, D., Lan, R., Colles, F. M., Mensa, P., Wieler, L. H., Karch, H., Reeves, P. R., Maiden, M. C. J., Ochman, H., et al. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05172.x · Cited by 2,075

Extensive mosaic structure revealed by the complete genome sequence of uropathogenic Escherichia coli

Welch, R. A., Burland, V., Plunkett, G., Redford, P., Roesch, P. L., Rasko, D. A., Buckles, E. L., Liou, S., Boutin, A., Hackett, J. D., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252529799 · Cited by 1,523

Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome Sequencing

Pizza, M., Scarlato, V., Masignani, V., Giuliani, M. M., Aricò, B., Comanducci, M., Jennings, G. T., Baldi, L., Bartolini, E., Capecchi, B., et al. (2000) · Science · doi:10.1126/science.287.5459.1816 · Cited by 1,403

Organised Genome Dynamics in the Escherichia coli Species Results in Highly Diverse Adaptive Paths

Touchon, M., Hoede, C., Tenaillon, O., Barbe, V., Baeriswyl, S., Bidet, P., Bingen, É., Bonacorsi, S., Bouchier, C., Bouvet, O. M. M., et al. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000344 · Cited by 1,248

Escherichia coli Induces DNA Double-Strand Breaks in Eukaryotic Cells

Nougayrède, J.-P., Homburg, S., Taieb, F., Boury, M., Brzuszkiewicz, E., Gottschalk, G., Buchrieser, C., Hacker, J., Dobrindt, U., & Oswald, E. (2006) · Science · doi:10.1126/science.1127059 · Cited by 1,188

Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem

Russo, T. A., & Johnson, J. R. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00049-2 · Cited by 801

Expert system for predicting protein localization sites in gram‐negative bacteria

Nakai, K., & Kanehisa, M. I. (1991) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340110203 · Cited by 756

PSORTb v.2.0: Expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis

Gardy, J. L., Laird, M. R., Chen, F., Rey, S., Walsh, C. J., Ester, M., & Brinkman, F. S. L. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bti057 · Cited by 719

Escherichia coli γ-carbonic anhydrase: characterisation and effects of simple aromatic/heterocyclic sulphonamide inhibitors

Prete, S. D., Bua, S., Supuran, C. T., & Capasso, C. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2020.1800670 · Cited by 37

Recombinant bacterial vaccines

Unnikrishnan, M., Rappuoli, R., & Serruto, D. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.03.013 · Cited by 37

Antibodies against Hemolysin and Cytotoxic Necrotizing Factor Type 1 (CNF1) Reduce Bladder Inflammation in a Mouse Model of Urinary Tract Infection with Toxigenic Uropathogenic Escherichia coli

Smith, M. A., Weingarten, R. A., Russo, L. M., Ventura, C. L., & O’Brien, A. D. (2015) · Infection and Immunity · doi:10.1128/iai.02848-14 · Cited by 36

The use of databases, data mining and immunoinformatics in vaccinology: where are we?

Hegde, N. R., Gauthami, S., Kumar, H. M. S., & Bayry, J. (2017) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1413088 · Cited by 38

A secretome view of colonisation factors in Shiga toxin-encoding Escherichia coli (STEC): from enterohaemorrhagic E. coli (EHEC) to related enteropathotypes.

Monteiro, R., Ageorges, V., Rojas-Lopez, M., Schmidt, H., Weiss, A., Bertin, Y., Forano, E., Jubelin, G., Henderson, I., Livrelli, V., et al. (2016) · FEMS Microbiology Letters · doi:10.1093/femsle/fnw179 · Cited by 29

Immunoinformatics and Epitope Prediction

Ramana, J., & Mehla, K. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0389-5_6 · Cited by 37

Identification of a novel prophage regulator in Escherichia coli controlling the expression of type III secretion

Flockhart, A. F., Tree, J. J., Xu, X., Karpiyevich, M., McAteer, S. P., Rosenblum, R., Shaw, D. J., Low, C. J., Best, A., Gannon, V. P. J., et al. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07927.x · Cited by 35

Comparative Pathogenomics ofEscherichia coli: Polyvalent Vaccine Target Identification through Virulome Analysis

Clark, J. R., & Maresso, A. W. (2021) · Infection and Immunity · doi:10.1128/iai.00115-21 · Cited by 33

Endosialidases: Versatile Tools for the Study of Polysialic Acid

Jakobsson, E., Schwarzer, D., Jokilammi, A., & Finne, J. (2012) · Topics in current chemistry · doi:10.1007/128_2012_349 · Cited by 36

The Intimin-Like Protein FdeC Is Regulated by H-NS and Temperature in Enterohemorrhagic Escherichia coli

Easton, D. M., Allsopp, L. P., Phan, M., Moriel, D. G., Goh, G. K., Beatson, S. A., Mahony, T. J., Cobbold, R. N., & Schembri, M. A. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.02114-14 · Cited by 33

Novel vaccine antigen combinations elicit protective immune responses against Escherichia coli sepsis

Mellata, M., Mitchell, N. M., Schödel, F. P., Curtiss, R., & Pier, G. B. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.12.014 · Cited by 32

Comparative genomics of multiple plasmids from APEC associated with clonal outbreaks demonstrates major similarities and identifies several potential vaccine-targets

Olsen, R. H., Christensen, H. K., & Bisgaard, M. (2012) · Veterinary Microbiology · doi:10.1016/j.vetmic.2012.03.008 · Cited by 30

EspA-loaded mesoporous silica nanoparticles can efficiently protect animal model against enterohaemorrhagic E. coli O157: H7

Hajizade, A., Salmanian, A. H., Amani, J., Ebrahimi, F., & Arpanaei, A. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1529676 · Cited by 30

The role of structural proteomics in vaccine development: recent advances and future prospects

Donnarumma, D., Faleri, A., Costantino, P., Rappuoli, R., & Norais, N. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2016.1121113 · Cited by 30

Anion Inhibition Studies of the Beta-Carbonic Anhydrase from Escherichia coli

Prete, S. D., Luca, V. D., Nocentini, A., Scaloni, A., Mastrolorenzo, M. D., Supuran, C. T., & Capasso, C. (2020) · Molecules · doi:10.3390/molecules25112564 · Cited by 29

Secreted proteases: A new insight in the pathogenesis of extraintestinal pathogenic Escherichia coli

Tapader, R., Basu, S., & Pal, A. (2019) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2019.03.002 · Cited by 29

Three-dimensional reconstructions of the bacteriophage CUS-3 virion reveal a conserved coat protein I-domain but a distinct tailspike receptor-binding domain

Parent, K. N., Tang, J., Giovanni Cardone, A., Gilcrease, E. B., Janssen, M. E. W., Olson, N. H., Casjens, S., & Baker, T. S. (2014) · Virology · doi:10.1016/j.virol.2014.06.017 · Cited by 28

EsiB, a Novel Pathogenic Escherichia coli Secretory Immunoglobulin A-Binding Protein Impairing Neutrophil Activation

Pastorello, I., Paccani, S. R., Rosini, R., Mattera, R., Ferrer‐Navarro, M., Urosev, D., Nesta, B., Surdo, P. L., Vecchio, M. D., Rippa, V., et al. (2013) · mBio · doi:10.1128/mbio.00206-13 · Cited by 28

Comparison of Multilocus Sequence Analysis and Virulence Genotyping of Escherichia coli from Live Birds, Retail Poultry Meat, and Human Extraintestinal Infection

Danzeisen, J. L., Wannemuehler, Y. M., Nolan, L. K., & Johnson, T. J. (2013) · Avian Diseases · doi:10.1637/10218-042812-resnote.1 · Cited by 28

Phylogenetic group‐associated differences in regulation of the common colonization factor Mat fimbria in E scherichia coli

Lehti, T. A., Bauchart, P., Kukkonen, M., Dobrindt, U., Korhonen, T., & Westerlund‐Wikström, B. (2013) · Molecular Microbiology · doi:10.1111/mmi.12161 · Cited by 26

‘Omic’ Approaches to Study Uropathogenic Escherichia coli Virulence

Lo, A. W. H., Moriel, D. G., Phan, M., Schulz, B. L., Kidd, T. J., Beatson, S. A., & Schembri, M. A. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.04.006 · Cited by 26

O-specific polysaccharide confers lysozyme resistance to extraintestinal pathogenic Escherichia coli

Bao, Y., Zhang, H., Huang, X., Ma, J., Logue, C. M., Nolan, L. K., & Li, G. (2018) · Virulence · doi:10.1080/21505594.2018.1433979 · Cited by 25

Murine Model of Chemotherapy-Induced Extraintestinal Pathogenic Escherichia coli Translocation

Green, S. I., Ajami, N. J., Ma, L. M., Poole, N. M., Price, R. E., Petrosino, J. F., & Maresso, A. W. (2015) · Infection and Immunity · doi:10.1128/iai.00684-15 · Cited by 25

Identification of novel vaccine candidates against carbapenem resistant Klebsiella pneumoniae: A systematic reverse proteomic approach

Mehmood, A., Naseer, S., Ali, A., Fatimah, H., Rehman, S., & Kiani, A. K. (2020) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2020.107380 · Cited by 23

YghJ, the secreted metalloprotease of pathogenic E. coli induces hemorrhagic fluid accumulation in mouse ileal loop

Tapader, R., Bose, D., & Pal, A. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.02.020 · Cited by 25

The Effect of Substituted Benzene-Sulfonamides and Clinically Licensed Drugs on the Catalytic Activity of CynT2, a Carbonic Anhydrase Crucial for Escherichia coli Life Cycle

Prete, S. D., Luca, V. D., Bua, S., Nocentini, A., Carginale, V., Supuran, C. T., & Capasso, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114175 · Cited by 23

Composição química e concentração mínima bactericida de dezesseis óleos essenciais sobre Escherichia coli enterotoxigênica

de Souza, A. A., Dias, N. A. A., Píccoli, R. H., & Bertolucci, S. K. V. (2016) · Revista Brasileira de Plantas Medicinais · doi:10.1590/1983-084x/15_050 · Cited by 22

High efficiency biosynthesis of O-polysaccharide-based vaccines against extraintestinal pathogenic Escherichia coli

Jiang, X., Bai, J., Yuan, J., Zhang, H., Lu, G., Wang, Y., Jiang, L., Liu, B., Wang, L., Huang, D., et al. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.117475 · Cited by 22

Vaccination Approaches for the Prevention of Urinary Tract Infection

Moriel, D. G., & Schembri, M. A. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201014666131226144824 · Cited by 21

Molecular and cellular insight into Escherichia coli SslE and its role during biofilm maturation

Corsini, P. M., Wang, S., Rehman, S., Fenn, K. L., Sagar, A., Sirovica, S., Cleaver, L. M., Edwards‐Gayle, C. J. C., Mastroianni, G., Dorgan, B., et al. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00272-5 · Cited by 22

Bacteria- and Phage-Derived Proteins in Phage Infection

Guliy, O. I., & Yevstigneyeva, S. S. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl24478 · Cited by 20

Identification and characterization of new broad host-range rV5-like coliphages C203 and P206 directed against enterobacteria

Sváb, D., Falgenhauer, L., Rohde, M., Chakraborty, T., & Tóth, I. (2018) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2018.07.004 · Cited by 20

Implications of enterotoxigenicEscherichia coligenomics for vaccine development

Sjöling, Å., von Mentzer, A., & Svennerholm, A. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2015.996553 · Cited by 21

Absence of Global Stress Regulation in Escherichia coli Promotes Pathoadaptation and Novel c-di-GMP-dependent Metabolic Capability

Zlatkov, N., & Uhlin, B. (2019) · Scientific Reports · doi:10.1038/s41598-019-39580-w · Cited by 20

UTI patients have pre-existing antigen-specific antibody titers against UTI vaccine antigens

Sarkissian, C. A., Alteri, C. J., & Mobley, H. L. T. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.07.031 · Cited by 19

Characterization of a Four-Component Regulatory System Controlling Bacteriocin Production in Streptococcus gallolyticus

Proutière, A., du Merle, L., Périchon, B., Varet, H., Gominet, M., Trieu‐Cuot, P., & Dramsi, S. (2021) · mBio · doi:10.1128/mbio.03187-20 · Cited by 21

SslE (YghJ), a Cell-Associated and Secreted Lipoprotein of Neonatal Septicemic Escherichia coli, Induces Toll-Like Receptor 2-Dependent Macrophage Activation and Proinflammation through NF-κB and MAP Kinase Signaling

Tapader, R., Bose, D., Dutta, P., Das, S., & Pal, A. (2018) · Infection and Immunity · doi:10.1128/iai.00399-18 · Cited by 20

Reverse vaccinology: A strategy also used for identifying potential vaccine antigens in poultry

Gloanec, N., Guyard‐Nicodème, M., Chemaly, M., & Dory, D. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.126756 · Cited by 21

Functional and structural characteristics of bacterial proteins that bind host cytokines

Högbom, M., & Ihalin, R. (2017) · Virulence · doi:10.1080/21505594.2017.1363140 · Cited by 18

Occurrence and Antimicrobial Resistance of Escherichia coli in Oysters and Mussels from Atlantic Canada

Rees, E. E., Davidson, J., Fairbrother, J. M., Hilaire, S. S., Saab, M. E., & McClure, J. T. (2014) · Foodborne Pathogens and Disease · doi:10.1089/fpd.2014.1840 · Cited by 18

Role in proinflammatory response of YghJ, a secreted metalloprotease from neonatal septicemic Escherichia coli

Tapader, R., Bose, D., Basu, P., Mondal, M., Mondal, A., Chatterjee, N. S., Dutta, P., Basu, S., Bhadra, R. K., & Pal, A. (2016) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2016.06.003 · Cited by 18

Complete Genome Sequence of the Multidrug-Resistant Neonatal Meningitis Escherichia coli Serotype O75:H5:K1 Strain mcjchv-1 (NMEC-O75)

Nielsen, D. W., Ricker, N., Barbieri, N. L., Wynn, J. L., Gomez-Duarte, O. G., Iqbal, J., Nolan, L. K., Allen, H. K., & Logue, C. M. (2018) · Microbiology Resource Announcements · doi:10.1128/mra.01043-18 · Cited by 17

Genome-Based Bacterial Vaccines: Current State and Future Outlook

Schubert‐Unkmeir, A., & Christodoulides, M. (2013) · BioDrugs · doi:10.1007/s40259-013-0034-5 · Cited by 16

Challenges in development of vaccines directed toward antimicrobial resistant bacterial species

Brazzoli, M., Piccioli, D., & Marchetti, F. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2228669 · Cited by 18

Analysis of immune responses to recombinant proteins from strains of Mycoplasma mycoides subsp. mycoides, the causative agent of contagious bovine pleuropneumonia

Perez‐Casal, J., Prysliak, T., Maina, T., Wang, Y., Townsend, H. G. G., Berverov, E., Nkando, I. G., Wesonga, H., Liljander, A., Jores, J., et al. (2015) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2015.08.013 · Cited by 16

BPSL1626: Reverse and Structural Vaccinology Reveal a Novel Candidate for Vaccine Design against Burkholderia pseudomallei

Capelli, R., Peri, C., Villa, R., Nithichanon, A., Conchillo‐Solé, O., Yero, D., Gagni, P., Chiari, M., Lertmemongkolchai, G., Cretich, M., et al. (2018) · Antibodies · doi:10.3390/antib7030026 · Cited by 16

Crystal structure of c5321: a protective antigen present in uropathogenic Escherichia coli strains displaying an SLR fold

Urosev, D., Ferrer‐Navarro, M., Pastorello, I., Cartocci, E., Costenaro, L., Zhulenkovs, D., Maréchal, J., Leonchiks, A., Reverter, D., Serino, L., et al. (2013) · BMC Structural Biology · doi:10.1186/1472-6807-13-19 · Cited by 15

Immersing undergraduate students in the research experience

Wang, J. T. H., Schembri, M. A., Ramakrishna, M., Sagulenko, E., & Fuerst, J. A. (2012) · Biochemistry and Molecular Biology Education · doi:10.1002/bmb.20572 · Cited by 15

Novel genetic markers define a subgroup of pathogenicEscherichia colistrains belonging to the B2 phylogenetic group

Deshpande, N., Wilkins, M. R., Mitchell, H. M., & Kaakoush, N. O. (2015) · FEMS Microbiology Letters · doi:10.1093/femsle/fnv193 · Cited by 15

High throughput genomic and proteomic technologies in the fight against infectious diseases

Tanca, A., Deligios, M., Addis, M. F., & Uzzau, S. (2013) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.3027 · Cited by 13

Broiler lines divergently selected for digestive efficiency also differ in their susceptibility to colibacillosis

Calenge, F., Mignon-Grasteau, S., Chanteloup, N., Brée, A., Lalmanach, A.-C., & Schouler, C. (2013) · Avian Pathology · doi:10.1080/03079457.2013.873531 · Cited by 14

Designing Vaccines to Neutralize Effective Toxin Delivery by Enterotoxigenic Escherichia coli

Fleckenstein, J. M., & Sheikh, A. (2014) · Toxins · doi:10.3390/toxins6061799 · Cited by 14

Protective multi-epitope candidate vaccine for urinary tract infection

Oloomi, M., Javadi, M., Karam, M. R. A., Kheirvari, M., Haghri, Z., & Bouzari, S. (2020) · Biotechnology Reports · doi:10.1016/j.btre.2020.e00564 · Cited by 13

Mixed mucosal-parenteral immunizations with the broadly conserved pathogenic Escherichia coli antigen SslE induce a robust mucosal and systemic immunity without affecting the murine intestinal microbiota

Naïli, I., Vinot, J., Baudner, B. C., Bernalier‐Donadille, A., Pizza, M., Desvaux, M., Jubelin, G., D’Oro, U., & Buonsanti, C. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.10.008 · Cited by 12

Wnt5A-Mediated Actin Organization Regulates Host Response to Bacterial Pathogens and Non-Pathogens

Jati, S., Sengupta, S., & Sen, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.628191 · Cited by 11

Proteomic analysis of uropathogenicEscherichia coli

Cash, P. (2014) · Expert Review of Proteomics · doi:10.1586/14789450.2014.877845 · Cited by 11

Exploiting the power of OMICS approaches to produceE. coliO157 vaccines

Kalita, A., Kalita, M. K., & Torres, A. G. (2014) · Gut Microbes · doi:10.4161/19490976.2014.983769 · Cited by 11

The Synthesis and Characterisation of 2-methyl-N-((4-methylpyridine-2-yl)carbamothiol)benzamide: Its Preparation with Antibacterial Study

Adam, F., Fatihah, N. N., Ameram, N. B., Subramanıam, S., & Mubarrakh, S. A. (2016) · Journal of Physical Science · doi:10.21315/jps2016.27.2.7 · Cited by 11

Differential Regulation of the Surface-Exposed and Secreted SslE Lipoprotein in Extraintestinal Pathogenic Escherichia coli

Tan, L., Moriel, D. G., Totsika, M., Beatson, S. A., & Schembri, M. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162391 · Cited by 11

Comparison of motif-based and whole-unique-sequence-based analyses of phage display library datasets generated by biopanning of anti-Borrelia burgdorferi immune sera

Ionov, Y., & Rogovskyy, A. S. (2020) · PLoS ONE · doi:10.1371/journal.pone.0226378 · Cited by 10

Antigen Discovery in Bacterial Panproteomes

Yero, D., Conchillo‐Solé, O., & Daura, X. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0795-4_5 · Cited by 10

Biofilm-forming ability, antibiotic resistance and phylogeny of Escherichia coli isolated from extra intestinal infections of humans, dogs, and chickens

Gunathilaka, G. A. D. K. K., Dewasmika, W. A. P. M., Sandaruwan, U. M., Neelawala, N. G. A. K., Madhumali, G. E. D., Dissanayake, B. N., Priyantha, M. A. R., Prasada, D. V. P., & Dissanayake, D. R. A. (2024) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2023.102123 · Cited by 10

Genomic Insights into Drug Resistance and Virulence Platforms, CRISPR-Cas Systems and Phylogeny of Commensal E. coli from Wildlife

Alonso, C. A., de Toro, M., de la Cruz, F., & Torres, C. (2021) · Microorganisms · doi:10.3390/microorganisms9050999 · Cited by 10

Identifying genomic islands with deep neural networks

Assaf, R., Xia, F., & Stevens, R. L. (2021) · BMC Genomics · doi:10.1186/s12864-021-07575-5 · Cited by 11

Distinct Metabolic Features of Pathogenic Escherichia coli and Shigella spp. Determined by Label‐Free Quantitative Proteomics

Pettersen, V. K., Steinsland, H., & Wiker, H. G. (2020) · PROTEOMICS · doi:10.1002/pmic.202000072 · Cited by 9

Linking inherent O-Linked Protein Glycosylation of YghJ to Increased Antigen Potential

Thorsing, M., Krogh, T. J., Vitved, L., Nawrocki, A., Jakobsen, R., Larsen, M. R., Chakraborty, S., Bourgeois, A. L., Andersen, A. Z., & Boysen, A. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.705468 · Cited by 9

An Introduction to Microbial Genomic Islands for Evolutionary Adaptation and Pathogenicity

Saini, A., Mani, I., Rawal, M. K., Verma, C., Singh, V., & Mishra, S. K. (2023) · Springer eBooks · doi:10.1007/978-981-19-9342-8_1 · Cited by 10

Evaluation of Recombinant Attenuated Salmonella Vaccine Strains for Broad Protection against Extraintestinal Pathogenic Escherichia coli

Maddux, J. T., Stromberg, Z. R., Curtiss, R., & Mellata, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01280 · Cited by 9

In Silico Design of a Poly-epitope Vaccine for Urinary Tract Infection Based on Conserved Antigens by Modern Vaccinology

Javadi, M., Oloomi, M., & Bouzari, S. (2020) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-020-10137-0 · Cited by 9

Occurrence and antibacterial susceptibility pattern of bacterial pathogens isolated from diarrheal patients in Pakistan

Rasool, M. H., Siddique, A. B., Saqalein, M., Asghar, M., Zahoor, M. A., Aslam, B., Shafiq, H. B., & Nisar, M. A. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.3.14449 · Cited by 9

Efficient Autotransporter-Mediated Extracellular Secretion of a Heterologous Recombinant Protein by Escherichia coli

Beriotto, I., Icke, C., Sevastsyanovich, Y. R., Rossiter, A. E., Romagnoli, G., Savino, S., Hodges, F. J., Cole, J. A., Saul, A. J., MacLennan, C. A., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03594-22 · Cited by 8

Evolution of Vaccines Formulation to Tackle the Challenge of Anti-Microbial Resistant Pathogens

Tognetti, F., Biagini, M., Denis, M., Berti, F., Maione, D., & Stranges, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512054 · Cited by 8

Vaccination: A Public Health Intervention That Changed History & Is Changing with History

Stein, R. A. (2011) · The American Biology Teacher · doi:10.1525/abt.2011.73.9.3 · Cited by 7

Identification of lipid A deacylase as a novel, highly conserved and protective antigen against enterohemorrhagic Escherichia coli

Rojas-López, M., Martinelli, M., Brandi, V., Jubelin, G., Polticelli, F., Soriani, M., Pizza, M., Desvaux, M., & Rosini, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-53197-z · Cited by 7

Glycosylation of bacterial antigens changes epitope patterns

Kern, K., Delaroque, N., Boysen, A., Puder, M., Wendt, R. T., Kölsch, A., Ehrentreich‐Förster, E., Stærk, K., Andersen, T. E., Andersen, K., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1258136 · Cited by 8

Complete Genome Sequence of the Escherichia coli PMV-1 Strain, a Model Extraintestinal Pathogenic E. coli Strain Used for Host-Pathogen Interaction Studies

Peris-Bondia, F., Muraille, É., & Melderen, L. V. (2013) · Genome Announcements · doi:10.1128/genomea.00913-13 · Cited by 7

Development of an O-polysaccharide based recombinant glycoconjugate vaccine in engineered E. coli against ExPEC O1

Jiang, X., Bai, J., Zhang, H., Yuan, J., Lu, G., Wang, Y., Jiang, L., Liu, B., Huang, D., & Feng, L. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118796 · Cited by 7

Recent Advances in Bioconjugate Vaccine Development

Wren, B. W., Hall, C. L., Terra, V. S., Harrison, M. A., Atkins, E., Nasher, F., & Passmore, I. J. (2025) · Vaccines · doi:10.3390/vaccines13070703 · Cited by 6

Paratransgenic quantum vaccinology

Contreras, M., Sobrino, I., & de la Fuente, J. (2024) · Trends in Parasitology · doi:10.1016/j.pt.2024.10.006 · Cited by 6

NIAID Workshop Report: Systematic Approaches for ESKAPE Bacteria Antigen Discovery

Sastalla, I., Kwon, K., Huntley, C. C., Taylor, K. L., Brown, L. L., Samuel, T., & Zou, L. (2025) · Vaccines · doi:10.3390/vaccines13010087 · Cited by 6

Delineating Surface Epitopes of Lyme Disease Pathogen Targeted by Highly Protective Antibodies of New Zealand White Rabbits

Rogovskyy, A. S., Caoili, S. E. C., Ionov, Y., Piontkivska, H., Skums, P., Tsyvina, V., Zelikovsky, A., & Waghela, S. D. (2019) · Infection and Immunity · doi:10.1128/iai.00246-19 · Cited by 6

Human Gut Microbiome: A Potential Prospective to Counter Antibiotic-Resistant Pathogens

Yadav, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819265-8.00005-x · Cited by 6

Progress toward a vaccine for extraintestinal pathogenic E. coli (ExPEC) II: efficacy of a toxin-autotransporter dual antigen approach

Xing, Y., Clark, J. R., Chang, J. D., Zulk, J. J., Chirman, D. M., Piedra, F.-A., Vaughan, E. E., Santos, H. H., Patras, K. A., & Maresso, A. W. (2024) · Infection and Immunity · doi:10.1128/iai.00440-23 · Cited by 6

In Silico Identification of Novel Potential Vaccine Candidates in Streptococcus pneumoniae

Wadhwani, A., & Khanna, V. (2016) · Global Journal of Technology and Optimization · doi:10.4172/2229-8711.s1109 · Cited by 6

Structure, Function, and Assembly of Adhesive Organelles by Uropathogenic Bacteria

Chahales, P., & Thanassi, D. G. (2016) · ASM Press eBooks · doi:10.1128/9781555817404.ch14 · Cited by 6

Current Scientific Advances in Vaccines Against UTIs: Challenges and Prospects

Wang, B., Wang, Y., Liu, H., Yu, M., Wang, S., Liu, L., Wang, H., Zhang, D., & Tan, H. (2025) · Microorganisms · doi:10.3390/microorganisms13122714 · Cited by 5

Structural vaccinology approaches to enhance efficacy, stability, and delivery of protective antigens

Samal, S. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13395-4.00007-1 · Cited by 5

Advancing vaccine development in genomic era: a paradigm shift in vaccine discovery

Din, M. U., Liu, X., Jiang, H., Ahmad, S., Lai, X., & Wang, X. (2025) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/adb2c8 · Cited by 6

Complete genome sequence of C130_2, a novel myovirus infecting pathogenic Escherichia coli and Shigella strains

Sváb, D., Falgenhauer, L., Rohde, M., Chakraborty, T., & Tóth, I. (2018) · Archives of Virology · doi:10.1007/s00705-018-4042-0 · Cited by 5

[Reverse vaccinology: strategy against emerging pathogens].

Monterrubio-López, G. P., & Delgadillo-Gutiérrez, K. (2021) · PubMed · Cited by 5

Proportions of IgA antibodies targeting glycosylated epitopes of secreted Escherichia coli mucinase YghJ in initial plasmablast response differ from salivary and intestinally secreted IgA

Riaz, S., Steinsland, H., Andersen, A. Z., Boysen, A., & Hanevik, K. (2024) · Medical Microbiology and Immunology · doi:10.1007/s00430-024-00812-0 · Cited by 5

Vaccine Design in the 21st Century

Bottomley, M. J., Rappuoli, R., & Finco, O. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802174-3.00003-5 · Cited by 5

Subcellular localisation of lipoproteins of Vibrio vulnificus by the identification of outer membrane vesicles components

Zhang, Y., Lin, H., Wang, P., Chen, C., & Chen, S. (2018) · Antonie van Leeuwenhoek · doi:10.1007/s10482-018-1092-y · Cited by 5

Characterization of Glycosylation-Specific Systemic and Mucosal IgA Antibody Responses to Escherichia coli Mucinase YghJ (SslE)

Riaz, S., Steinsland, H., Thorsing, M., Andersen, A. Z., Boysen, A., & Hanevik, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.760135 · Cited by 5

Reservoirs of Extraintestinal PathogenicEscherichia coli

Manges, A. R., & Johnson, J. R. (2016) · ASM Press eBooks · doi:10.1128/9781555817404.ch9 · Cited by 5

Targeting plasmid-encoded proteins that contain immunoglobulin-like domains to combat antimicrobial resistance

Prieto, A., Miró, L., Margolles, Y., Bernabeu, M., Salguero, D., Merino, S., Tomás, J. M., Sánchez, J. A. C., Pérez‐Bosque, A., Hüttener, M., et al. (2024) · eLife · doi:10.7554/elife.95328.3 · Cited by 5

Genomics of Escherichia and Shigella

Perna, N. T. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7686-4_5 · Cited by 5

Antibacterial Vaccine Research in 21st Century: From Inoculation to Genomics Approaches

Altındiş, E. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113136660188 · Cited by 5

Erratum for Wallenstein et al., “ClbR Is the Key Transcriptional Activator of Colibactin Gene Expression in Escherichia coli”

Wallenstein, A., Rehm, N., Brinkmann, M., Selle, M., Bossuet‐Greif, N., Sauer, D., Bunk, B., Spröer, C., Wami, H. T., Homburg, S., et al. (2020) · mSphere · doi:10.1128/msphere.00727-20 · Cited by 6

Identification of Candidates for a Subunit Vaccine against Extraintestinal Pathogenic Escherichia coli

Durant, L., Métais, A., Soulama-Mouze, C., Genevard, J.-M., Nassif, X., & Escaich, S. (2006) · Infection and Immunity · doi:10.1128/iai.01269-06 · Cited by 64

Characterization of a novel Escherichia coli IgA-binding antigen impairing neutrophil activation

Pastorello, I. (2012) · Padua Research Archive (University of Padova)

A Novel Protective Vaccine Antigen from the Core Escherichia coli Genome

Moriel, D. G., Tan, L., Goh, K., Phan, M., Ipe, D., Lo, A. W., Peters, K. M., Ulett, G., Beatson, S., & Schembri, M. (2016) · Msphere · doi:10.1128/msphere.00326-16 · Cited by 40

Progress toward a vaccine for extraintestinal pathogenic E. coli (ExPEC) II: efficacy of a toxin-autotransporter dual antigen approach

Xing, Y., Clark, J. R., Chang, J. D., Zulk, J. J., Chirman, D. M., Piedra, F.-A., Vaughan, E. E., Santos, H. H., Patras, K. A., & Maresso, A. W. (2024) · Infection and Immunity · doi:10.1128/iai.00440-23 · Cited by 6

A Multiepitope Subunit Vaccine Conveys Protection against Extraintestinal Pathogenic Escherichia coli in Mice

Wieser, A., Romann, E., Magistro, G., Hoffmann, C., Nörenberg, D., Weinert, K., & Schubert, S. (2010) · Infection and Immunity · doi:10.1128/iai.00174-10 · Cited by 92